Management appointments at Kinex Pharmaceuticals
This article was originally published in Scrip
Kinex Pharmaceuticals has appointed Dr Allen Barnett president emeritus and Dr Johnson Lau CEO. Dr Barnett, who steps aside as the company's CEO, has agreed to stay on at Kinex after serving at the company since its inception. Dr Lau, who has been Kinex's executive chairman since its founding, was previously chairman and CEO of Ribapharm. He has also worked for ICN Pharmaceuticals, Schering-Plough and Roth Capital Partners.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.